Nureca Ltd's initial public offer (IPO) is set to open for subscription next week on February 15, 2021, after it received capital market regulator Sebi?s approval to raise Rs 100 crore through public issue

The bids for the issue can be made for a minimum of 35 equity shares and in multiples subsequently. Up to 75 percent of the net issue will be reserved for Qualified Institutional Buyers (QIB).  For eligible employees, share amounting to Rs. 50 lakh shall be reserved and will be on offer at a discount of Rs. 20 per share.

The company has reserved not more than 10 percent of the issue for the retail investors and the remaining 15 percent for the Non-Institutional category. The issue also includes a reservation of equity shares worth Rs 50 lakh for subscription by eligible employees. A discount of Rs 20 per share is also being offered to eligible employees bidding in the employee reservation portion.

As per the Nureca?s RHP, the current addressable segments for Nureca in India and neighbouring countries are Chronic Disease Products, Mother and child care and Orthopedic products. They sell their products through their brand portfolios. Dr Trust, Trumom and Dr Physio. In October 2019, Nureca joined hands with Croma, country?s first omni-channel electronics retailer from the Tata Group, to emerge as the very first company to sell healthcare/wellness products through Croma stores.

ITI Capital Ltd is the sole book-running lead manager and Link Intime India Private is the registrar to the issue.

Sensex, Nifty End Flat With A Negative Bias, Spicejet flies 1 pc

TCS to recruit 1,500 tech employees in UK next year

Home loan Biz: SBI crosses Rs 5 trillion-mark